Financial News · Live Terminal

Page 864 of 867

Pro Medicus Unit Secures AU$37 Million Contract Renewal With Illinois Health System

Pro Medicus' (ASX:PME) Visage Imaging subsidiary signed a five-year contract renewal worth AU$37 million with Northwestern Medicine, an academic health system based in Illinois, according to a Monday filing with the Australian bourse.

ASX:PME

Asia91d ago

Brambles Says Court Returned Mixed Verdict in Class Action Over Guidance Disclosures

Brambles (ASX:BXB) said Australia's Federal Court on April 10 dismissed several claims and upheld others in a class action filed by certain shareholders who alleged the company made misleading guidance disclosures to the market between August 2016 and February 2017, according to a Monday filing with the Australian bourse.The court dismissed all claims related to medium-term targets for fiscal 2019, and also dismissed several claims related to Brambles' fiscal 2017 guidance, per the filing.However, in relation to the fiscal 2017 guidance, the court upheld claims related to underlying profit growth forecasts made between Nov. 16, 2016, and Dec. 21, 2016, as well as the claims related to underlying profit growth and sales revenue growth targets issued between Dec. 21, 2016, and Jan. 23, 2017.Brambles, which has insurance arrangements in place, is reviewing the decision and evaluating its options. The company said the amount of potential damages is currently uncertain.Shares of Brambles were down 1% in recent Monday trading.

ASX:BXB

Asia91d ago

Magnetic Resources Lodges Draft Scheme Booklet With ASIC for Genesis Minerals Deal

Magnetic Resources (ASX:MAU) said it has lodged a draft scheme booklet with the Australian Securities and Investments Commission (ASIC) and ASX for review, containing an independent expert's report for its proposed scheme of arrangement under which it will be acquired by Genesis Minerals (ASX:GMD), according to a Monday Australian bourse filing.The company said the scheme booklet is expected to be made available to shareholders in early May, with an updated scheme timetable to be provided following the first court hearing scheduled for April 28.The company said its board continues to consider the scheme to be in the best interests of shareholders and recommends it be approved at the scheme meeting, in the absence of a superior proposal and subject to the independent expert concluding the scheme remains in shareholders' best interests.

ASX:GMDASX:MAU

Asia91d ago

Kingsgate Consolidated Reports March Quarter Production; Maintains Fiscal Year 2026 Guidance

Kingsgate Consolidated (ASX:KCN) produced 21,036 ounces of gold and 182,549 ounces of silver in the March quarter, according to a Monday filing with the Australian bourse.The company also reported total cash, bullion, and doré of AU$213 million as of March 31, up roughly 19% from the December 2025 quarter."Looking ahead, we remain firmly on track to achieve [fiscal year 2026] guidance and are focused on delivering a strong final quarter," said Kingsgate Managing Director and Chief Executive Jamie Gibson.

ASX:KCN

Asia91d ago

Monash IVF Group Receives Sweetened Takeover Offer From Genesis, Soul Patts Consortium; Shares Climb 19%

Monash IVF Group (ASX:MVF) received a revised, unsolicited, conditional, and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP Holdings (ASX:SOL) to acquire all its shares by way of a scheme of arrangement at AU$0.90 per share, according to a Monday Australian bourse filing.The consortium, which currently owns a 19.6% stake in Monash IVF, previously made an indicative proposal at AU$0.80 per share.The company said the consortium described the offer price as the highest amount it is prepared to offer in the absence of a competing proposal, with the proposal valid until the close of business on April 21.The proposal is subject to several conditions, including exclusive due diligence with no fiduciary exceptions, negotiation and execution of transaction documentation on customary terms, unanimous board recommendation, and final internal approval from consortium members.The Monash IVF board is assessing the proposal with the assistance of financial adviser Macquarie Capital and legal adviser Clayton Utz, the filing added.Monash IVF Group's shares surged 19% in recent Monday trade, while WHSP Holdings' shares shed 1%.

ASX:MVFASX:SOL

Asia91d ago

BMC Minerals Receives Positive Development Decision for Canada Project

BMC Minerals (ASX:BMC) said it has received a positive decision document for the development of the ABM Mine at its Kudz Ze Kayah Project in Canada, issued by the Government of Yukon, Natural Resources Canada, and the Department of Fisheries and Oceans Canada, according to a Monday Australian bourse filing.The company said the decision follows a recommendation for approval by the Yukon Environmental and Socio-economic Assessment Board in 2020, with ten new terms covering five areas, including financial oversight, operational performance, socio-economic participation, heritage resources, and road access.BMC will continue the permitting process for all remaining permits and licenses for the project, including the Quartz Mining License and Type A and B Water Licenses, the filing added.

ASX:BMC

Asia91d ago

GQG Partners March Funds Under Management Rise Year Over Year

GQG Partners (ASX:GQG) said its funds under management (FUM) stood at $162.5 billion at the end of March, according to a Monday filing with the Australian bourse.The company had reported FUM of $161.9 billion at the close of March 2025, according to an earlier filing.In March 2026, international equity FUM increased to $72.2 billion from $63.7 billion a year earlier, while global equity FUM fell to $37.7 billion from $40 billion.Emerging-market equity FUM fell to $38.2 billion from $39.1 billion year over year, and US equity FUM declined to $14.4 billion from $19.1 billion.

ASX:GQG

Asia91d ago

ASX Preview: Australian Shares Set to Open Lower as US Announces Iran Blockade; Monash IVF Receives Revised Takeover Proposal

Australian shares are set to open lower on Monday after US President Donald Trump said that the US would begin a blockade of the Strait of Hormuz after peace talks between Iran and the US ended without a resolution to the conflict, sending oil prices higher.A report from The Wall Street Journal said that Trump and his advisers were considering limited ⁠strikes on Iran. Brent crude oil futures soared nearly 8% to a four-week high of $US102.80 per barrel early on Monday. Gold fell almost 2%.In corporate news, Monash IVF Group (ASX:MVF) received a revised, unsolicited, conditional, and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP Holdings (ASX:SOL) to acquire 100% of the shares in Monash IVF via a scheme of arrangement at $0.90 per share.Pro Medicus' (ASX: PME) wholly-owned US unit, Visage Imaging, signed a AU$37 million, five-year contract renewal with Northwestern Medicine.Australia's benchmark index closed just 0.1% lower, or 12.6 points, at 8,960.60 on April 10.

ASX 200ASX:MVFASX:PMEASX:SOL

Asia91d ago

Telix Pharmaceuticals, Regeneron Form Radiopharmaceutical Partnership

Telix Pharmaceuticals (ASX:TLX) said it entered into a collaboration with Nasdaq-listed Regeneron Pharmaceuticals to jointly develop and commercialize next-generation radiopharmaceutical therapies, according to a Monday Australian bourse filing.Under the deal, Telix will receive $40 million upfront for four initial programs, the filing said. The collaboration will combine Telix's expertise in radiopharmaceutical development and manufacturing with Regeneron's antibody discovery and oncology experience.Telix said it has the option to co-fund commercialization and profit-share, or earn up to an aggregate of $2.1 billion in development and commercial milestone payments plus low double-digit royalties.Should Telix opt out of the co-funding model for a particular program, it is instead eligible to receive up to $535 million in development and commercial milestones plus low double-digit royalties on future net sales for that program, per the filing.The companies will also jointly develop diagnostic assets, with Telix leading the commercialization and Regeneron receiving a set percentage of profits, the filing said.

ASX:TLX

Asia91d ago

Regal Partners Names Chair-Elect

Regal Partners (ASX:RPL) appointed Peter Yates as chair-elect, effective Monday, according to a same-day Australian bourse filing.Yates will stand for election at the company's annual general meeting on May 28, the filing said, adding that Michael Cole will retire as the chair after the meeting.Yates is the current chairman of AIA Australia.

ASX:RPL

Asia91d ago

Champion Iron Completes Acquisition of Norwegian Iron Ore Producer

Champion Iron (ASX:CIA) completed its voluntary cash tender offer to acquire all of the issued and outstanding shares of Norway-based iron ore producer, Rana Gruber, at 79 Norwegian kroner each in cash, according to a Monday Australian bourse filing.Acceptances of the offer were received from a total of 34.3 million shares held by Rana Gruber's shareholders, representing 92.48% of issued and outstanding shares, the filing said.Champion plans to carry out a compulsory acquisition of the remaining shares of Rana Gruber in accordance with applicable Norwegian securities laws after the completion, per the filing. It also plans to take steps to delist Rana Gruber's shares from the Euronext Oslo Bors.

ASX:CIA

Asia91d ago

St Barbara Receives Approval to Industrial Permit Changes for Canada Mine Restart

St Barbara (ASX:SBM) received approval of amendments to the industrial approval permit conditions to resume operations at the Touquoy mine from the Nova Scotia Department of Environment and Climate Change in Canada, according to a Monday filing with the Australian bourse.Operating cash flow from the restart is anticipated to be CA$118 million at $4,000 per ounce over 13 months with gold production of 38,000 ounces from 3 million tonnes of stockpiles grading 0.4 grams per tonne, the filing said.The company expects Touquoy to resume ore processing by the end of the year, the filing said.

ASX:SBM

Asia91d ago

Synlait Milk Says Enhanced Formula Products Testing Caused Extended Release Times; Production Back to Target Levels

Synlait Milk (NZE:SML, ASX:SM1) said it implemented enhanced testing earlier this year for all infant formula products, which resulted in extended release times and also had an impact on working capital requirements, according to a Monday filing with the New Zealand bourse.The company issued the statement in response to a same-day disclosure from the a2 Milk Company (NZE:ATM, ASX:A2M), which said there is a backlog of unfilled purchase orders at the Synlait plants that produce infant milk formula.Synlait said it has worked through the associated supply chain impacts with the support of the a2 Milk Company, adding that "production has recently returned to targeted levels."Synlait said it has also been impacted by the supply chain issues noted in the a2 Milk Company's filing, including product release and clearance times, a shifting regulatory landscape, and a challenging geopolitical and trading environment.

ASX:A2MASX:SM1NZE:ATMNZE:SML

Asia91d ago

Atlas Arteria Says BlackRock Increases Stake

Atlas Arteria (ASX:ALX) said BlackRock Group and its subsidiaries have increased their stake in the company on April 9 to 7.12% or 103.5 million shares from 6.07% or 88.1 million shares, according to a Monday Australian bourse filing.

ASX:ALX

Asia91d ago

Tivan Appoints COO

Tivan (ASX:TVN) said Robert Gerrard was appointed as its Chief Operating Officer, effective April 20, according to a Monday Australian bourse filing.He was recently the senior director of energy and resources at Kellogg Brown & Root.

ASX:TVN

Asia91d ago

a2 Milk Co. Cuts Guidance on China Supply Issues; Shares Fall 13%

a2 Milk Co. (NZE:ATM, ASX:A2M) said its infant milk formula business in China is experiencing "temporary in-market product availability issues" that will likely impact the company's performance in fiscal 2026, resulting in a cut to guidance, according to a Monday filing with the New Zealand and Australian bourses.The issues primarily relate to shortfalls of China-label infant milk formula product at distributors and retailers for several reasons, including high demand for the company's imported products amid product recalls by international competitors, per the filing.At the same time, the Middle East conflict has had a direct impact on the availability and cost of air freight for product shipments to China, and inventory levels have been low through the fiscal year to date as a result of previous manufacturing challenges at Synlait's (NZE:SML, ASX:SM1) plant, where there remains "a significant backlog" of unfilled purchase orders, the company said.Additionally, new standards for related to enhanced cereulide testing are extending quality assurance release times, while higher inspection and sampling rates for the industry are extending clearance release times, per the filing.a2 Milk said these factors will have a material impact on China-label infant milk formula availability in the fiscal fourth quarter, mainly in April and May. The company now expects fiscal 2026 revenue growth in the low to mid double-digit range, compared with mid double-digits previously. Its earnings before interest, taxes, depreciation, and amortization percent margin is expected to be about 14% to roughly 15%, compared with 16% previously.The company also expects lower interest income for fiscal 2026 due to lower market rates and net transaction cash outflows.Its Kiwi shares were down 13% in recent Monday trading.

ASX:A2MASX:SM1NZE:ATMNZE:SML

Asia91d ago

Fonterra Co-operative Group Names Richard Allen as Next CEO; Shares Tumble 30%

Fonterra Co-operative Group (NZE:FCG) named Richard Allen as its next chief executive, effective May 1, succeeding Miles Hurrell, according to a Monday filing with the New Zealand bourse.Allen most recently served as president of global ingredients at Fonterra, per the filing.Hurrell will stay with the company in an advisory role until September to facilitate the transition.Fonterra's shares were down 30% in recent Monday trading.

NZE:FCG

Asia91d ago

Fonterra Co-operative Group Implements Over NZ$3 Billion Capital Return; Shares Dive 30%

Fonterra Co-operative Group's (NZE:FCG) roughly NZ$3.2 billion capital return to shareholders was implemented on April 10, according to a Monday filing with the New Zealand bourse.Payments to shareholders and unit holders will be processed on Tuesday, the company said.Fonterra's shares plummeted 30% in recent Monday trade.

NZE:FCG

Asia93d ago

Yuzhou Group Logs 482 Million Yuan in March Contracted Sales

Yuzhou Group (HKG:1628) recorded contracted sales of 482 million yuan in March, with a sales area of 37,351 square meters, according to a Friday Hong Kong bourse filing.The property company's average selling price stood at approximately 12,907 yuan per square meter for the month.In the first quarter of 2026, the accumulated sales amount was 1.37 billion yuan, with a sales area of 108,232 square meters and an average selling price of 12,700 yuan per square meter.

HKG:1628

Asia93d ago

Alco's Co-Chairs Steps Down; Successors Named

Alco (HKG:0328) said co-chairpersons Liao Liping and Tian Yi have resigned effective Friday to devote more time to their personal endeavors, according to a same-day Hong Kong bourse filing.The consumer electronics company, on the same day, named Pan Ying as its new chair.Pan has served as the CEO of Shengjun Capital since March 2021.

HKG:0328

Showing 17261-17280 of 17323